Latest Regulatory Progress News

Brazilian Critical Minerals releases a robust Bankable Feasibility Study for its Ema Rare Earth Project, highlighting a US$1.47 billion post-tax NPV and a swift 0.5-year payback period, underpinned by low capital and operating costs.

Audalia Resources (ASX: ACP) is seeking to raise $450,000 through a placement of 15 million shares at 3 cents each, aiming to fund the Medcalf project’s progression and shore up working capital.

Australian Rare Earths (ASX: AR3) has announced a maiden Ore Reserve of 26 million tonnes at 920 ppm TREO for its Koppamurra Rare Earths Project, underpinned by a robust Pre-Feasibility Study delivering an A$858 million post-tax NPV and a rapid payback of less than one year.

The a2 Milk Company has announced a $300 million fully franked special dividend following regulatory clearance in China to rebrand infant formula products under its a2 label.

EBR Systems has wrapped up the retail tranche of its fully underwritten entitlement offer, adding A$10.9 million to a total raise of about A$43.6 million to support its wireless cardiac pacing technology.

Patriot Resources has independently confirmed the reliability of historical assay data at its Tassa Silver-Gold Project in Peru, reinforcing confidence in its 31.4Moz inferred resource and clearing regulatory hurdles ahead of a maiden drill campaign.

Emyria’s new treatment-resistant depression program shows statistically significant symptom improvements in a small initial cohort, expanding its mental health therapy offerings beyond PTSD.

Caravel Minerals has lifted the confidence in its Caravel Copper Project with a 48% increase in Proved Ore Reserve tonnage, maintaining stable total contained copper while adding new metal grades to the reserve estimate.

Island Pharmaceuticals has won a key regulatory boost as the US FDA granted Orphan Drug Designation to Galidesivir for post-exposure prophylaxis of Marburg virus disease, enhancing its commercial and development prospects.

The Federal Court of Australia has approved IsoEnergy's acquisition of Toro Energy, setting the stage for Toro's shares to be suspended and the deal to complete later this month.

Heartland Group Holdings has satisfied all initial conditions for its acquisition of TSB Bank shares from Toi Foundation, moving closer to a December 2026 merger that will create TSB Heartland Bank Limited.

TruScreen has secured clinical validation from the world’s largest cervical screening study in China, setting the stage for rapid market expansion across Asia, Africa, and Europe.